NCT03353545View on ClinicalTrials.gov

Retrospective and Prospective Study of POmalidomide Plus LoW Dose Dexa Efficacy in RRMM Patients Under Real-Life Conditions

CompletedOBSERVATIONAL
Enrollment

110

Participants

Timeline

Start Date

November 16, 2017

Primary Completion Date

February 21, 2020

Study Completion Date

February 28, 2020

Conditions
Relapse/Refractory Multiple Myeloma
Trial Locations (1)

Unknown

Ag.Andreas General Hospital, Pátrai

Sponsors
All Listed Sponsors
lead

Genesis Pharma S.A.

INDUSTRY

NCT03353545 - Retrospective and Prospective Study of POmalidomide Plus LoW Dose Dexa Efficacy in RRMM Patients Under Real-Life Conditions | Biotech Hunter | Biotech Hunter